Sader, Helio S <br/><br/>
Antimicrobial Susceptibility Trends among Staphylococcus aureus Isolates from U.S. Hospitals: Results from 7 Years of the Ceftaroline (AWARE) Surveillance Program, 2010 to 2016.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  09 2017 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1098-6596 
<br/><br/><label>Standard No.: </label>10.1128/AAC.01043-17  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Bacterial Agents--therapeutic use<br/>Cephalosporins--therapeutic use<br/>Clindamycin--therapeutic use<br/>Erythromycin--therapeutic use<br/>Humans<br/>Levofloxacin--therapeutic use<br/>Methicillin-Resistant Staphylococcus aureus--drug effects<br/>Microbial Sensitivity Tests--trends<br/>Staphylococcal Skin Infections--drug therapy<br/>Tetracycline--therapeutic use<br/>Trimethoprim, Sulfamethoxazole Drug Combination--therapeutic use<br/>United States<br/>Ceftaroline